Erratum: MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer (Cancer Cell (2017) 32(1) (71–87.e7) (S1535610817302544) (10.1016/j.ccell.2017.06.004))

Surendra K. Shukla, Vinee Purohit, Kamiya Mehla, Venugopal Gunda, Nina V. Chaika, Enza Vernucci, Ryan J. King, Jaime Abrego, Gennifer D. Goode, Aneesha Dasgupta, Alysha L. Illies, Teklab Gebregiworgis, Bingbing Dai, Jithesh J. Augustine, Divya Murthy, Kuldeep S. Attri, Oksana Mashadova, Paul M. Grandgenett, Robert Powers, Quan P LyAudrey J Lazenby, Jean L Grem, Fang Yu, José M. Matés, John M. Asara, Jung whan Kim, Jordan H. Hankins, Colin Weekes, Michael A Hollingsworth, Natalie J. Serkova, Aaron R. Sasson, Jason B. Fleming, Jennifer M. Oliveto, Costas A. Lyssiotis, Lewis C. Cantley, Lyudmyla Berim, Pankaj Singh

Research output: Contribution to journalComment/debatepeer-review

44 Scopus citations

Abstract

(Cancer Cell 32, 71–87; July 10, 2017) In the originally published version of the paper, author Natalie J. Serkova's name was spelled incorrectly as “Sarkova.” The correct spelling of the name is “Serkova,” and the error has been corrected in the original article online. The authors apologize for this error.

Original languageEnglish (US)
Pages (from-to)392
Number of pages1
JournalCancer Cell
Volume32
Issue number3
DOIs
StatePublished - Sep 11 2017

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum: MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer (Cancer Cell (2017) 32(1) (71–87.e7) (S1535610817302544) (10.1016/j.ccell.2017.06.004))'. Together they form a unique fingerprint.

Cite this